Evaluation and Management of Premature Ventricular Complexes

Area of Science:

• Cardiology
• Electrophysiology
• Preventive Medicine

Background:

• Premature ventricular complexes (PVCs) are highly prevalent, affecting most individuals during long-term monitoring.
• Factors such as increasing age, height, blood pressure, heart disease history, inactivity, and smoking correlate with higher PVC frequency.
• While PVC causes are not fully understood, potential mechanisms include triggered activity, automaticity, and reentry.

Purpose of the Study:

• To review the diagnosis, evaluation, and management of premature ventricular complexes (PVCs).
• To discuss the prognostic implications and therapeutic strategies for patients with PVCs.
• To highlight areas for future research in PVCs and associated conditions.

Main Methods:

• Review of clinical presentation, diagnostic tools (ECG, echocardiogram, MRI, ambulatory monitoring), and risk factors for PVCs.
• Analysis of current treatment guidelines, including medical management (beta-blockers, calcium channel blockers, antiarrhythmics) and catheter ablation.
• Examination of the relationship between PVC frequency, ventricular function, and adverse outcomes like heart failure.

Main Results:

• PVCs are often asymptomatic but can cause symptoms like palpitations and fatigue.
• Diagnosis relies on history, physical exam, ECG, and may involve echocardiography, MRI, and ambulatory monitoring.
• Successful catheter ablation can resolve PVC-induced systolic dysfunction, indicating a causal link.

Conclusions:

• Prognosis for PVCs is variable, with ongoing research needed to identify predictors of adverse outcomes.
• For symptomatic PVCs or those with reduced ejection fraction, medical therapy or catheter ablation are first-line treatments.
• Further research is essential to identify individuals at risk for PVC-induced cardiomyopathy and develop targeted preventative and therapeutic strategies.